A Hungarian company aiming to reform oncology R&D through a simulated cell model received ~HUF 8 Bn through venture funding
Article in Hungarian. read more
News
Announcement
Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform
Biotech entrepreneur Mark Velleca is Board Chair, seasoned cancer biology advisors Gordon Mills and Klaus Hoeflich join Scientific Advisory Board. read more
Cancer drugs forecasting startup Turbine secures €20 million series A
Merck & Co's strategic investment fund was revealed as a co-lead investor. read more
They can find the needle in a haystack – this Hungarian tech company received ~HUF 8 Bn to fight cancer
Article in Hungarian. read more
Simulations for experiments: Bayer-backed startup lands $20M to test out its tech
How do you get the attention of Big Pharma when you’re a small biotech startup working out of Budapest, Hungary? For Szabolcs Nagy and his… read more
Turbine Announces €20-Million Series A behind Digital Cell Platform
The cell behavior simulation platform tackles oncology program needs by supporting clinical pipeline decisions read more